---
title: 'Diagnosis and management of hypersensitivity pneumonitis in adults: A position
  statement from the Thoracic Society of Australia and New Zealand'
date: '2024-10-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39467777/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241029183704&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Hypersensitivity pneumonitis (HP) is an immune-mediated interstitial
  lung disease (ILD) relating to specific occupational, environmental or medication
  exposures. Disease behaviour is influenced by the nature of exposure and the host
  response, with varying degrees of lung inflammation and fibrosis seen within individuals.
  The differentiation of HP from other ILDs is important due to distinct causes, pathophysiology,
  prognosis and management implications. This Thoracic Society of Australia and ...
disable_comments: true
---
Hypersensitivity pneumonitis (HP) is an immune-mediated interstitial lung disease (ILD) relating to specific occupational, environmental or medication exposures. Disease behaviour is influenced by the nature of exposure and the host response, with varying degrees of lung inflammation and fibrosis seen within individuals. The differentiation of HP from other ILDs is important due to distinct causes, pathophysiology, prognosis and management implications. This Thoracic Society of Australia and ...